<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-HUEGVBR5</identifier><date>1996</date><creator>Ocvirk, Janja</creator><creator>Štabuc, Borut</creator><relation>documents/doc/H/URN_NBN_SI_doc-HUEGVBR5_001.pdf</relation><relation>documents/doc/H/URN_NBN_SI_doc-HUEGVBR5_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 35-40</format><identifier identifier_type="COBISSID_HOST">8663769</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-HUEGVBR5</identifier><language>slv</language><publisher>Onkološki inštitut</publisher><source>Novosti v sistemskem zdravljenju in pri zdravljenju kronične bolečine</source><rights>InC</rights><subject language_type_id="slv">Anemia</subject><subject language_type_id="slv">Drug therapy</subject><subject language_type_id="slv">Erythropoietin</subject><subject language_type_id="slv">Neoplasms</subject><title>Rekombinantni humani eritropoietin za zdravljenje anemije rakavih bolnikov</title></Record>